| 2024 | A Case of Nivolumab-Induced Bullous Pemphigoid in a Patient with Metastatic Breast Cancer | 최혜영; 최유원; 변지연; 노주영 | Article |
| 2019 | Asian Society of Gynecologic Oncology International Workshop 2018 | 김승철 | Review |
| 2024 | Dissecting transcriptome signals of anti-PD-1 response in lung adenocarcinoma | 이상혁; 김재상 | Article |
| 2024 | Four versus six cycles of platinum-based chemotherapy for advanced Urothelial carcinoma in the era of immune checkpoint inhibitors: A retrospective cohort study (FOCUS, KCSG-GU23-08) | 조정민 | Article |
| 2024 | Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer | 이경은 | Article |
| 2022 | Impact of gender on response to immune checkpoint inhibitors in patients with non-small cell lung cancer undergoing second- or later-line treatment | 최명근 | Article |
| 2016 | Intrathecal-specific glutamic acid decarboxylase antibodies at low titers in autoimmune neurological disorders | 문장섭 | Article |
| 2024 | Metabolic reprogramming of the tumor microenvironment to enhance immunotherapy | 임선아 | Review |
| 2025 | Optimization of immunotherapy-based combinations for metastatic renal cell carcinoma: A network meta-analysis | 이정연 | Review |
| 2022 | Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease | 이용현 | Review |
| 2021 | PI3K gamma delta inhibitor plus radiation enhances the antitumour immune effect of PD-1 blockade in syngenic murine breast cancer and humanised patient-derived xenograft model | 나득채 | Article |
| 2025 | Regulatory T Cell Metabolism: A Promising Therapeutic Target for Cancer Treatment? | 임선아 | Article |
| 2019 | The 34th annual meeting of the korean society of gynecologic oncology 2019: Meeting report | 김승철 | Article |
